146 related articles for article (PubMed ID: 11034589)
1. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk.
Yu MW; Pai CI; Yang SY; Hsiao TJ; Chang HC; Lin SM; Liaw YF; Chen PJ; Chen CJ
Gut; 2000 Nov; 47(5):703-9. PubMed ID: 11034589
[TBL] [Abstract][Full Text] [Related]
2. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine.
Farker K; Schotte U; Scheele J; Hoffmann A
Exp Toxicol Pathol; 2003 Jun; 54(5-6):387-91. PubMed ID: 12877350
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
[TBL] [Abstract][Full Text] [Related]
4. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
[TBL] [Abstract][Full Text] [Related]
5. CYP2C19 Genotype Could be a Predictive Factor for Aggressive Manifestations of Hepatocellular Carcinoma Related with Chronic Hepatitis B Infection in Thailand.
Nun-Anan P; Chonprasertsuk S; Siramolpiwat S; Tangaroonsanti A; Bhanthumkomol P; Pornthisarn B; Vilaichone RK
Asian Pac J Cancer Prev; 2015; 16(8):3253-6. PubMed ID: 25921128
[TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
7. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
[TBL] [Abstract][Full Text] [Related]
8. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population.
Liu Y; Liu Y; Huang X; Sui J; Mo C; Wang J; Peng Q; Deng Y; Huang L; Li S; Qin X
Infect Genet Evol; 2014 Oct; 27():69-76. PubMed ID: 25014269
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
[TBL] [Abstract][Full Text] [Related]
10. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
[TBL] [Abstract][Full Text] [Related]
11. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
[TBL] [Abstract][Full Text] [Related]
12. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
13. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
[TBL] [Abstract][Full Text] [Related]
14. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
15. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
[TBL] [Abstract][Full Text] [Related]
16. Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigation.
Farker K; Schotte U; Scheele J; Hoffmann A
Int J Clin Pharmacol Ther; 2002 Mar; 40(3):120-4. PubMed ID: 11911601
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Tsai JF; Chuang LY; Ho MS; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Chang JG
Medicine (Baltimore); 2008 Mar; 87(2):87-98. PubMed ID: 18344806
[TBL] [Abstract][Full Text] [Related]
18. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
19. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
20. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
Zhang QX; Yao YQ; Li SL; Long Q
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
